As of Mar 22
| -0.92 / -1.52%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 69.00, with a high estimate of 77.00 and a low estimate of 64.00. The median estimate represents a +15.79% increase from the last price of 59.59.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.